Perovskite-structured Ultrasensitive CaMnO3 Nanoenzyme Enables Highly Efficient Ultrasound-Amplified and Catalysis-Involved Synergistic Tumor Therapy

Ying Wang,Xinyue Cao,Xiaoyan Li,Liang Chen,Meiqi Chang,Yu Chen,Bingcang Huang
DOI: https://doi.org/10.1016/j.cej.2024.154236
IF: 15.1
2024-01-01
Chemical Engineering Journal
Abstract:Catalytic nanoenzyme-mediated therapy with reactive oxygen species generation feature and tumor microenvironment regulation characteristic has demonstrated high therapeutic efficacy in oncological field, whereas its low enzyme-mimicking reaction efficacy typically results in dissatisfied therapeutic effect and outcome. Herein, an ultrasensitive CaMnO3 (CMO) nanoenzyme has been rationally designed and engineered for enzyodynamiccalcium overload synergistic tumor therapy. CMO nanoenzyme with oxidase (OXD)-, peroxidase (POD)- and glutathione peroxidase (GPx)-mimic activities is responsible for the generation of reactive oxygen species, the consumption of intra-tumor glutathione and mitochondrial damage. For the evaluation of OXD and PODmimicking activities, CMO with ultra low concentration (1 mu g ml- 1) can rapidly catalyze the color reaction of 3,3 ',5,5 '-tetramethylbenzidine (TMB) hydrochloride and reach the reaction termination in a very short time (1 s). Moreover, the release and overload of Ca2+ strengthen the tumor cell death. Exogenous ultrasound stimulation further amplifies the enzyodynamic-Ca2+ overload synergistic tumor-therapeutic efficacy. In vitro and in vivo results affirm the transcendent antineoplastic outcomes of CMO. Meanwhile, the existence of Mn2+ endows nanoenzyme with T1-weighted MR imaging capacity. This work provides new strategies for efficient enzymemimicking activity and tumor synergistic treatment based on new perspectives on the engineering of multifunctional therapeutic nanomedicine.
What problem does this paper attempt to address?